Skip to Main Content

Paper Details

Risk of Late-Onset Breast Cancer in Genetically Predisposed Women.
J Clin Oncol
16
2021
BRCA1, BRCA2, Breast Cancer, CHEK2, CHEK2 PVs, ER, ER-negative breast cancer, PALB2, PALB2 and CHEK2 PVs, Women, breast cancer, estrogen, estrogen receptor, germline predisposition gene, penetrance gene, predisposition genes, triple-negative breast cancer, women
Author NameAffiliation
Peter KraftHarvard University T.H. Chan School of Public Health
Peter KraftHarvard University T.H. Chan School of Public Health
Katherine L NathansonPerelman School of Medicine at the University of Pennsylvania
Katherine L NathansonBasser Center for BRCA, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
David E GoldgarUniversity of Utah
David E GoldgarUniversity of Utah
Dimitrios TrichopoulosUniversity of Wisconsin-Madison
Christopher G ScottMayo Clinic
Janet E OlsonMayo Clinic
Loic Le MarchandUniversity of Hawaii Cancer Center
Charles KooperbergFred Hutchinson Cancer Research Center
David J HunterUniversity of Oxford
David J HunterUniversity of Oxford
Christopher A HaimanKeck School of Medicine, University of Southern California
Christopher A HaimanKeck School of Medicine, University of Southern California
Mia M Gaudet
James V LaceyBeckman Research Institute of City of Hope
James V LaceyBeckman Research Institute of City of Hope
Leslie BernsteinBeckman Research Institute of City of Hope
Paul L AuerUWM Joseph J. Zilber School of Public Health
Christine B AmbrosoneRoswell Park Comprehensive Cancer Center
Christine B AmbrosoneRoswell Park Comprehensive Cancer Center
Eric C PolleyMayo Clinic
Eric C PolleyMayo Clinic
Susan M DomchekPerelman School of Medicine at the University of Pennsylvania
Susan M DomchekBasser Center for BRCA, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
  • 1 - 28

Datasets

Release 1.2